Bambusa Therapeutics, Inc. (BBTX)

Bambusa Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Bambusa Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-52.62	-44.01	-13.88
Net Income	-48.7	-39.33	-

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	71.48	90.63	9.36
Total Debt	-	0	0
Net Cash (Debt)	71.48	90.63	9.36
Net Cash Growth	-	868.03%	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-40.9	-39.8	-4.63
Free Cash Flow	-40.9	-39.8	-4.63
Free Cash Flow Growth	-	-	-